1. Home
  2. SCLXW vs HUBCW Comparison

SCLXW vs HUBCW Comparison

Compare SCLXW & HUBCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • HUBCW
  • Stock Information
  • Founded
  • SCLXW N/A
  • HUBCW N/A
  • Country
  • SCLXW United States
  • HUBCW Israel
  • Employees
  • SCLXW 31
  • HUBCW 322
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • HUBCW
  • Sector
  • SCLXW Health Care
  • HUBCW
  • Exchange
  • SCLXW Nasdaq
  • HUBCW Nasdaq
  • Market Cap
  • SCLXW N/A
  • HUBCW N/A
  • IPO Year
  • SCLXW N/A
  • HUBCW N/A
  • Fundamental
  • Price
  • SCLXW $0.14
  • HUBCW $0.02
  • Analyst Decision
  • SCLXW
  • HUBCW
  • Analyst Count
  • SCLXW 0
  • HUBCW 0
  • Target Price
  • SCLXW N/A
  • HUBCW N/A
  • AVG Volume (30 Days)
  • SCLXW 4.0K
  • HUBCW N/A
  • Earning Date
  • SCLXW 03-07-2025
  • HUBCW N/A
  • Dividend Yield
  • SCLXW N/A
  • HUBCW N/A
  • EPS Growth
  • SCLXW N/A
  • HUBCW N/A
  • EPS
  • SCLXW N/A
  • HUBCW N/A
  • Revenue
  • SCLXW $55,152,000.00
  • HUBCW N/A
  • Revenue This Year
  • SCLXW N/A
  • HUBCW N/A
  • Revenue Next Year
  • SCLXW N/A
  • HUBCW N/A
  • P/E Ratio
  • SCLXW N/A
  • HUBCW N/A
  • Revenue Growth
  • SCLXW 22.02
  • HUBCW N/A
  • 52 Week Low
  • SCLXW $0.18
  • HUBCW N/A
  • 52 Week High
  • SCLXW $0.18
  • HUBCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW 33.86
  • HUBCW 41.39
  • Support Level
  • SCLXW $0.14
  • HUBCW $0.02
  • Resistance Level
  • SCLXW $0.25
  • HUBCW $0.02
  • Average True Range (ATR)
  • SCLXW 0.05
  • HUBCW 0.00
  • MACD
  • SCLXW -0.01
  • HUBCW 0.00
  • Stochastic Oscillator
  • SCLXW 10.79
  • HUBCW 58.02

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About HUBCW Hub Cyber Security Ltd. Warrant 2/27/28

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: